[Clinical prevalence and reason for visit of patients with generalized anxiety disorder seen in the psychiatry out-patient clinics in Spain. Results of the LIGANDO study]
- PMID: 18815907
[Clinical prevalence and reason for visit of patients with generalized anxiety disorder seen in the psychiatry out-patient clinics in Spain. Results of the LIGANDO study]
Abstract
Introduction: Generalized anxiety disorder (GAD) is frequent and has a great impact on quality of life. Its prevalence in the general population and in primary care has been established previously in Spain; however it still must be determined in the mental health.
Methods: An epidemiological, multicenter and cross-sectional study was carried out, collecting demographic data, reason for consultation and presence of GAD diagnosis according to ICD-10 criteria of their first 75 visiting patients on a randomly selected representative sample of 312 psychiatrists.
Results: Data from 20,347 subjects was recorded. Clinic prevalence of GAD was 13.7% (95% confidence interval: 13.3-14.2). The most frequent reason for psychiatric consultation was depressive symptoms (26.7%) followed by symptoms of anxiety (18.2%). In 71.4% of GAD patients, the reason for consultation was anxiety symptoms.
Conclusions: GAD clinic prevalence in Spain is high. Almost one out of three GAD-patients visits the psychiatrist office for a reason other than this condition.
Similar articles
-
[Clinical and epidemiologic study of "generalized anxiety" in general practice].Encephale. 1994 Mar-Apr;20(2):103-10. Encephale. 1994. PMID: 8050376 French.
-
[Validation of the PRIME-MD for the detection of generalized anxiety disorder].Invest Clin. 2008 Mar;49(1):39-48. Invest Clin. 2008. PMID: 18524330 Spanish.
-
[Prevalence of depressive disorders in consultation-liaison psychiatry].Actas Esp Psiquiatr. 2001 Mar-Apr;29(2):75-83. Actas Esp Psiquiatr. 2001. PMID: 11333524 Spanish.
-
[Economic and epidemiologic aspects of generalized anxiety disorder: a review of the literature].Actas Esp Psiquiatr. 2008 May-Jun;36(3):165-76. Actas Esp Psiquiatr. 2008. PMID: 18478457 Review. Spanish.
-
The epidemiology of generalized anxiety disorder in Europe.Eur Neuropsychopharmacol. 2005 Aug;15(4):445-52. doi: 10.1016/j.euroneuro.2005.04.010. Eur Neuropsychopharmacol. 2005. PMID: 15951160 Review.
Cited by
-
Modelling the cost-effectiveness of pregabalin versus usual care in daily practice in the treatment of refractory generalised anxiety disorder in Spain.Soc Psychiatry Psychiatr Epidemiol. 2013 Jun;48(6):985-96. doi: 10.1007/s00127-012-0606-6. Epub 2012 Oct 21. Soc Psychiatry Psychiatr Epidemiol. 2013. PMID: 23086587
-
Pregabalin versus SSRIs and SNRIs in benzodiazepine-refractory outpatients with generalized anxiety disorder: a post hoc cost-effectiveness analysis in usual medical practice in Spain.Clinicoecon Outcomes Res. 2012;4:157-68. doi: 10.2147/CEOR.S31102. Epub 2012 Jun 13. Clinicoecon Outcomes Res. 2012. PMID: 22745564 Free PMC article.
-
Broadening of Generalized Anxiety Disorders Definition Does not Affect the Response to Psychiatric Care: Findings from the Observational ADAN Study.Clin Pract Epidemiol Ment Health. 2012;8:158-68. doi: 10.2174/1745017901208010158. Epub 2012 Nov 16. Clin Pract Epidemiol Ment Health. 2012. PMID: 23173012 Free PMC article.
-
Disability and health-related quality of life in outpatients with generalised anxiety disorder treated in psychiatric clinics: is there still room for improvement?Ann Gen Psychiatry. 2011 Mar 14;10(1):7. doi: 10.1186/1744-859X-10-7. Ann Gen Psychiatry. 2011. PMID: 21401940 Free PMC article.
-
Rapid screening for generalized anxiety disorder in patients with migraine.Curr J Neurol. 2021 Apr 4;20(2):102-110. doi: 10.18502/cjn.v20i2.6746. Curr J Neurol. 2021. PMID: 38011478 Free PMC article.